Article: NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates.

NuVasive, Inc. (NASDAQ:NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced the appointment of Michael J. Lambert as Executive Vice President and Chief Financial Officer, effective November 9, 2009. The Company also announced several other Executive Management Team updates (see also NuVasive, Inc.).

"Michael will be an excellent complement to the NuVasive family," said Alex Lukianov, Chairman and Chief Executive Officer of NuVasive. "He has proven himself to be a strong financial leader, including experience as the Chief Financial Officer of a medical device company with over $1 ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!